<?xml version="1.0" encoding="UTF-8"?>
<p id="Par31">Given that COVID-19 primarily causes respiratory symptoms and viral pneumonia with bilateral, peripheral and lower lung distribution, the pulmonary oedema that is observed in these patients, which is usually accompanied by ARDS, is mainly regarded as non-cardiogenic. However, given that approximately 25% of patients hospitalized with COVID-19 develop heart failure, the potential contribution of pulmonary congestion by heart failure should be taken into consideration
 <sup>
  <xref ref-type="bibr" rid="CR77">77</xref>
 </sup>. Additional haemodynamic data from patients with COVID-19-related respiratory failure are needed to validate this involvement.
</p>
